PRESS RELEASES

For Immediate Release

 

OurPet’s Releases Fourth Quarter and Year Results

·        Sales and Profit Improve

·        Litigation Settlement Results in Extraordinary Gain

·        Financial Position Strengthened

·        Board Members Convert $150,000 of Debt to Equity

·        Marketing & Sales Reorganized and Strengthened

·        Major New Products Launch Planned

Fairport Harbor, OH – February 17, 2004:  OurPet’s Company (OPCO OTCBB) today reported financial results for its fourth quarter and year ended December 31, 2003.  Net sales for the fourth quarter were $1,381,000, a decrease of 3% compared to $1,422,000 for the prior year fourth quarter.  Due to uncontrollable events, over $100,000 of sales slipped into the First Quarter of 2004.  Gross profit for the quarter was $300,000 or 22% of net sales compared to $418,000 or 29% of net sales for the prior year quarter.  This decrease in gross profit was caused by the change in product mix to an increase in sales of items with a lower gross margin.  The loss before extraordinary item for the quarter was $204,000 compared to income before extraordinary item of $53,000 for the same period in 2002.  This was the result of the decrease in gross profit and the write-off of tooling and inventory associated with discontinued products.  After the extraordinary item resulting from the litigation settlement the net income for the quarter was $644,000 compared to net income of $53,000 for the prior year.  Earnings per share were $0.06 vs. $.00 for the same period in 2002.

For the year net sales were $5,181,000, an increase of 10% compared to $4,693,000 for the prior year.  Gross profit for the year was $1,249,000 or 24% of net sales compared to $1,183,000 or 25% of net sales for the prior year.  The small decrease in percentage gross profit when net sales increased 10% was due to the change in product mix to items with a lower gross profit this year.  The loss before extraordinary item for the year was $408,000 compared to a loss of $270,000 in the prior year as a result of the write-off of tooling and inventory associated with discontinued products in the current year.  After the extraordinary item from the litigation settlement the net income for the current year was $440,000 compared to a net loss of $270,000 for the prior year or a $710,000 improvement.  Earnings per share were $.03 vs. ($.03) for 2002.

In December, OurPet’s finalized an agreement to settle all litigation with our former intellectual property counsel, their attorneys, and insurers.  In exchange for full and final releases of all claims between and among the parties, OurPet’s received approximately $879,000 after deductions for contingent and unpaid legal fees.  After deducting other legal fees and expenses incurred in the litigation, OurPet’s recognized an extraordinary gain of approximately $848,000 in 2003.  “We are very pleased to put this distraction behind us since a significant amount of financial and management resources were diverted to this activity during the last three years” said Dr. Tsengas.

The following table summarized financial highlights for the Fourth Quarter and Year:

 

Fourth Quarter

Year

 

2003

2002

2003

2002

Net Sales

$1,381,146

$1,422,458

$5,180,779

$4,693,222

Gross Profit

300,237

417,721

1,248,571

1,183,038

Income (Loss) From Operations

 (38,630)

 82,431

 (122,163)

(154,399)

Income (Loss) Before
Extraordinary Item   

 (203,942)

 52,671

(407,980)

(270,258)

Extraordinary Item

848,166

0

848,166

0

Net Income (Loss)

644,224

52,671

440,186

(270,258)

Basic and Diluted Earnings Per Share:

 

 

 

 

Income (Loss) Before    Extraordinary Item

 (0.02)

0.00

 (0.04)

 (0.03)

   Extraordinary Item

0.08

0.00

0.07

0.00

   Net Income (Loss)

0.06

0.00

0.03

(0.03)

Dr. Steven Tsengas, President and CEO stated “Although Fourth Quarter and results for the Year were disappointing, they do provide a strong base for future growth in sales and profits.” 

Key summary points: 

1.                  Net income for the year of $440,186 represents an improvement of $710,000 from 2002.  Although expense for the write-off of tooling and inventory associated with discontinued products impacted net income, it had no impact on the Company’s cash flow and should have a positive impact on future earnings due to reduced depreciation, personal property taxes, warehouse and handling costs.  Working Capital improved from $272,205 in 2002 to $977,334 or by $705,129 providing greater resources for future growth. 

2.                  Due to the improved net income and conversion of $150,000 in notes payable to equity by certain Board Members in 2003, OurPet’s balance sheet has been strengthened from 2002: 

·        Liquidity, as measured by the Current Ratio improved to 1.7 to 1.0 from 1.1 to 1.0

·        Debt was reduced to $927,323 from $1,564,393 or by 41% which will significantly reduce our interest expense

·        Shareholder’s equity improved by $590,186 to $1,650,575 

3.                  Marketing and Sales costs and activities were carefully reviewed and changes made to make OurPet’s more market driven and better focused.  Dr. Tsengas, working closely with both the Vice President of Marketing and the National Sales Manager, will play a much more active role with customers in the future. 

4.                  OurPet’s plans to officially launch approximately fifty (50) new, proprietary, innovative products at the American Pet Product Manufacturers (APPMA) Show in March 2004.  Although, some of these new products have begun generating revenues during the First Quarter of 2004, the major impact will be felt after the APPMA Show.

OurPet’s designs, produces and markets in the USA and overseas a broad line of innovative, high-quality accessory and consumable pet products. Investors and customers may visit www.ourpets.com for more information about the company and its products.  The APPMA * survey estimates the U.S. market for pet products at $32 billion, with a long-term annual growth rate of 10 percent.  The APPMA estimates an American pet population of 68 million dogs, 73 million cats and 19 million birds. 

            * APPMA, 2002/2003 National Pet Owners Survey

OURPET’S COMPANY AND SUBSIDIARIES

CONSOLIDATED OPERATING RESULTS 

 

For the Year Ended

December 31,

For the Quarter Ended

December 31,

 

2003

2002

2003

2002

 

 

 

 

 

Net revenue

$5,180,779

$4,693,222

$1,381,146

$1,422,458

Less:  Costs and expenses

  Cost of goods sold

 

3,932,208

 

3,510,184

 

1,080,909

 

1,004,737

  Selling, general and administrative expenses

1,370,734

1,337,437

338,867

335,290

Income (loss) from operations

(122,163)

(154,399)

(38,630)

82,431

  Other income and expense

(176,212)

3,954

(136,158)

891

  Interest expense

(109,605)

(119,813)

(29,154)

(30,651)

Income (loss) before extraordinary item

(407,980)

(270,258)

(203,942)

52,671

Extraordinary item – gain on litigation settlement

 848,166

 -

848,166

-

Net income (loss)

$440,186

$(270,258)

$644,224

$52,671

 

 

 

 

 

Basic and diluted earnings per common share after dividend requirements for Preferred  Stock: 

 

 

 

 

  Income (loss) before extraordinary item

$(0.04)

$(0.03)

$(0.02)

$-

  Extraordinary item

0.07

-

0.08

-

  Net income (loss)

$0.03

$(0.03)

$0.06

$-

 CONSOLIDATED BALANCE SHEETS 

 

December 31,

 

2003

2002

 

 

 

ASSETS

 

 

  Cash and equivalents

$36,592

$36,434

  Receivables, net

629,299

660,214

  Inventories

1,627,000

1,702,847

  Prepaid expenses

147,244

30,006

     Total current assets

2,440,135

2,429,501

  Property and equipment, net

661,863

806,054

  Other

114,331

136,124

 

 

 

     Total assets

$3,216,329

$3,371,679

 

 

 

LIABILITIES AND STOCKHOLDER’S EQUITY

 

 

  Short-term borrowings and current maturities of long-term debt

$824,370

$1,410,399

  Accounts payable

545,736

607,459

  Accrued expenses

92,695

139,438

     Total current liabilities

1,462,801

2,157,296

  Long-term debt

102,953

153,994

  Stockholders’ Equity

1,650,575

1,060,389

 

 

 

     Total liabilities and stockholders’ equity

$3,216,329

$3,371,679

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements contain the words "projects," "anticipates," "believes," "expects," "intends," "will," "may" and similar words and expressions.  Each such statement is subject to uncertainties, risks and other factors that could cause actual results or performance to differ materially from the results or performance expressed in or implied by such statements.  The forward-looking statements in this news release that contain projections of the company's expected financial performance and other projections regarding future performance are inherently subject to change, given the nature of projections, and the company's actual performance may be better or worse than projected.  Uncertainties, risks and other factors that may cause actual results or performance to differ materially from any results or performance expressed or implied by forward-looking statements in this news release include:  (1) the company’s ability to manage its operating expenses and realize operating efficiencies, (2) the company’s ability to maintain and grow its sales with existing and new customers, (3) the company’s ability to retain existing members of its senior management team and to attract additional management employees, (4) the company’s ability to manage fluctuations in the availability and cost of key materials and tools of production, (5) general economic conditions that might impact demand for the company’s products, (6) competition from existing or new participants in the pet products industry, (7) the company’s ability to design and bring to market new products on a timely and profitable basis,  (8) challenges to the company’s patents or trademarks on existing or new products, or (9) the company’s ability to secure access to sufficient capital on favorable terms to manage and grow its business.  A discussion of other risk factors that may cause actual results to differ from the results expressed in or implied by these forward-looking statements can be found in the company's periodic filings with the SEC.  The company disclaims any duty to provide updates to the forward-looking statements and projections made in this news release.

Contacts:
OurPet's Company
Dr. Steven Tsengas or John G. Murchie
440-354-6500